Blog

Advarra experts Joan Versaggi and Leslie Paul answer questions from the webinar- FDA Updates: BIMO – What Sponsors Need to Know.

Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.

An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.

An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.

Maintaining an effective partnership with your technology vendor is key to implementation success.

Clinical Research Workforce survey finds sites once had similar habits, but everyone is approaching the "next normal" differently.

Understand how to properly handle and evaluate incoming data gathered using mobile health (mHealth) apps and technologies.

Dr. Paul Evans, CEO of Velocity Clinical Research weighs in on what's missing in the discussion of decentralized trials.

While clinical research professionals are familiar with the role of the IRB to protect research subjects, most are unfamiliar with the added need for an Institutional Biosafety Committee (IBC).

Return on investment (ROI) is a critical metric for clinical research leadership. Read more for questions to ask as you evaluate your ROI.

Learn three strategies for how site centricity can ensure trial success and a positive experience for your participants.

eConsent is a way to enhance the patient experience through improved study design, retention rates, and communication.